Milind Deshpande
2017
In 2017, Milind Deshpande earned a total compensation of $2.2M as Former Director and Chief Executive Officer at Achillion Pharmaceuticals, a 26% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $260,703 |
|---|---|
| Option Awards | $1,335,258 |
| Salary | $607,700 |
| Other | $8,557 |
| Total | $2,212,218 |
Deshpande received $1.3M in option awards, accounting for 60% of the total pay in 2017.
Deshpande also received $260.7K in non-equity incentive plan, $607.7K in salary and $8.6K in other compensation.
Rankings
In 2017, Milind Deshpande's compensation ranked 5,025th out of 14,666 executives tracked by ExecPay. In other words, Deshpande earned more than 65.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,025 out of 14,666 | 66th |
Division Manufacturing | 1,791 out of 5,768 | 69th |
Major group Chemicals And Allied Products | 528 out of 2,074 | 75th |
Industry group Drugs | 407 out of 1,730 | 77th |
Industry Pharmaceutical Preparations | 323 out of 1,329 | 76th |
Source: SEC filing on April 15, 2019.
Deshpande's colleagues
We found two more compensation records of executives who worked with Milind Deshpande at Achillion Pharmaceuticals in 2017.